Delivering therapeutic cannabinoids via skin: Current state and future perspectives.

Journal of Controlled Release : Official Journal of the Controlled Release Society
Akeemat O TijaniAshana Puri

Abstract

Adequate evidence exists in the literature indicating a relatively positive shift with regards to the legal acceptance of cannabis and cannabis-derived products for medicinal purposes in some countries. Concomitantly, scientists are showing renewed interest in cannabis-related research work. Over the years, clinical and preclinical studies have demonstrated the therapeutic significance of cannabinoids for diverse indications. Additionally, efforts are being made to develop cannabis-related products into acceptable prescription products. FDA authorization for the commercial use of four cannabinoid-derived products, available as oral dosage forms is a significant progress already. However, there are certain drawbacks associated with the conventional delivery forms of cannabinoids. These include low oral bioavailability due to hepatic degradation, gastric instability, poor water solubility, and the side effects experienced upon the use of high doses of psychotropic cannabinoids associated with heightened plasma concentrations of the drug. These are however, limitable with the aid of transcutaneous drug delivery. Emerging topical and transdermal strategies could be exploited for the successful development of highly effective delive...Continue Reading

References

Jan 1, 1976·The Journal of Pharmacy and Pharmacology·J W FairbairnM G Rowan
May 1, 1991·Journal of Clinical Pharmacology·V V Ranade
Jul 1, 1974·Journal of Pharmaceutical Sciences·E R Garrett, C A Hunt
Dec 1, 1996·Pharmaceutical Research·R H Guy
Mar 4, 2000·Journal of Controlled Release : Official Journal of the Controlled Release Society·E TouitouM Eliaz
Sep 21, 2000·Pharmaceutical Science & Technology Today·A NaikR H Guy
Aug 14, 2001·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·B W Barry
Mar 22, 2003·Clinical Pharmacokinetics·Franjo Grotenhermen
Sep 2, 2003·Methods and Findings in Experimental and Clinical Pharmacology·A K Jain, R Panchagnula
Sep 23, 2003·Pain·Ahmet DogrulErdal Guzeldemir
Sep 23, 2003·Pain·Ozgur YesilyurtOguzhan Yildiz
Oct 23, 2003·Nature Reviews. Cancer·Manuel Guzmán
Feb 3, 2004·Nature Biotechnology·Brian W Barry
Mar 26, 2004·Nature Reviews. Drug Discovery·Mark R PrausnitzRobert Langer
May 26, 2004·International Journal of Pharmaceutics·Satyanarayana ValivetiAudra L Stinchcomb
Nov 5, 2004·The Journal of Pharmacology and Experimental Therapeutics·Bernard Le Foll, Steven R Goldberg
Jun 14, 2005·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Vikram SarveiyaHeather A E Benson
Nov 25, 2005·Current Drug Delivery·Heather A E Benson
Oct 4, 2006·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Satyanarayana ValivetiAudra L Stinchcomb
Oct 27, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Cristina BlázquezManuel Guzmán
Nov 2, 2006·Expert Opinion on Drug Delivery·Heather A E Benson
Dec 28, 2006·Pharmaceutical Research·Koji Kawahara, Kakuji Tojo
Mar 16, 2007·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·C CollinUNKNOWN Sativex Spasticity in MS Study Group
Nov 7, 2007·Pharmaceutical Research·Christophe HerkenneRichard H Guy
Dec 22, 2007·Expert Opinion on Investigational Drugs·Mellar P Davis
Feb 27, 2008·Critical Reviews in Therapeutic Drug Carrier Systems·Abhijit A Date, V B Patravale
Nov 11, 2008·Nature Biotechnology·Mark R Prausnitz, Robert Langer
May 22, 2009·Current Opinion in Chemical Biology·Stefania PetrosinoVincenzo Di Marzo
Jun 23, 2009·European Journal of Pharmacology·Tonia LucaGiuseppina Cantarella
Jul 18, 2009·Trends in Pharmacological Sciences·Tamás BíróPál Pacher
Jul 28, 2009·Current Drug Abuse Reviews·Zdenek Fisar
Aug 12, 2009·Experimental Dermatology·Piotr KupczykJacek C Szepietowski
Jan 1, 2008·Indian Journal of Pharmaceutical Sciences·Swati RawatG Srikarti
Jan 18, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Baris E PolatDaniel Blankschtein
Feb 22, 2011·Drug Testing and Analysis·Simon Hudson, John Ramsey
Dec 14, 2011·The Journal of Pharmacy and Pharmacology·Shital H BariyaOm Prakash Sharma
Dec 16, 2011·Journal of Advanced Pharmaceutical Technology & Research·Reshmy RajanDeepa T Vasudevan
Feb 9, 2012·International Journal of Molecular Sciences·Kovanya MoodleyPriya Bawa
Mar 8, 2012·Scientia pharmaceutica·Vinod DhoteDinesh K Mishra
Apr 26, 2012·Clinical Chemistry·Dayong LeeMarilyn A Huestis

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

British Journal of Hospital Medicine
William Notcutt
Mini Reviews in Medicinal Chemistry
María L López-Rodríguez
Journal of Pain and Symptom Management
Paul HowardAndrew Wilcock
British Medical Journal
D N Bateman, M D Rawlins
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
Scott A McLeod, Jean-François Lemay
© 2021 Meta ULC. All rights reserved